Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection
Marie Suehiro, Shinya Okubo, Kensuke Nakajima, Kosuke Kanda, Masanobu Hayakawa, Shigeru Oiso, Tsutomu Kabashima, Hideaki Fujita, Yukio Ando, Takahiro Muro
doi: https://doi.org/10.1101/2021.07.23.21261029
Marie Suehiro
1Division of Medical Informatics, Faculty of Pharmaceutical Sciences, Nagasaki International University
Shinya Okubo
2Division of Pharmaceutical Health Care and Science, Faculty of Pharmaceutical Sciences, Nagasaki International University
Kensuke Nakajima
2Division of Pharmaceutical Health Care and Science, Faculty of Pharmaceutical Sciences, Nagasaki International University
Kosuke Kanda
3Division of Clinical pharmaceutics, Faculty of Pharmaceutical Sciences, Nagasaki International University
Masanobu Hayakawa
3Division of Clinical pharmaceutics, Faculty of Pharmaceutical Sciences, Nagasaki International University
Shigeru Oiso
2Division of Pharmaceutical Health Care and Science, Faculty of Pharmaceutical Sciences, Nagasaki International University
Tsutomu Kabashima
4Division of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Nagasaki International University
Hideaki Fujita
5Section of Functional Morphology, Faculty of Pharmaceutical Sciences, Nagasaki International University
Yukio Ando
6Division of Amyloidosis Research, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
Takahiro Muro
1Division of Medical Informatics, Faculty of Pharmaceutical Sciences, Nagasaki International University
Data Availability
Due to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available.
Posted August 04, 2021.
Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection
Marie Suehiro, Shinya Okubo, Kensuke Nakajima, Kosuke Kanda, Masanobu Hayakawa, Shigeru Oiso, Tsutomu Kabashima, Hideaki Fujita, Yukio Ando, Takahiro Muro
medRxiv 2021.07.23.21261029; doi: https://doi.org/10.1101/2021.07.23.21261029
Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection
Marie Suehiro, Shinya Okubo, Kensuke Nakajima, Kosuke Kanda, Masanobu Hayakawa, Shigeru Oiso, Tsutomu Kabashima, Hideaki Fujita, Yukio Ando, Takahiro Muro
medRxiv 2021.07.23.21261029; doi: https://doi.org/10.1101/2021.07.23.21261029
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)